Whole exome sequencing is a technology that caused complete DNA sequence of any organism’s genome at the single time through the help of various laboratory processes. In the future of personalized medicine, whole genome sequence will play an important role in guiding the therapeutic intervention. Currently, it is being widely used for the identification and the determination of genetic variants causing various diseases such as Miller syndrome and Alzheimer’s disease.
Cost-effectiveness with the whole exome sequencing as compared with whole-genome sequencing along with global alliances among key research facilities are some of the factors that increasing the demand of the global whole exome sequencing market. Apart from this, increasing population along with rising incidences of cancer and other infectious diseases are also boosting the growth of the global market. In addition, high investments by companies, both new and old, are on R&D facilities in this technology is also impacting the growth of the market in a positive way. However, lack of skilled manpower and professionals and dependency on the government authorities for approvals and grants are the factors restraining the growth of the market.
On the basis of technology, the global whole exome sequencing market is segmented as sequencing by synthesis and sequencing by ion semiconductor. Based on the products, the market is segmented as instruments sequences, sequencing services, kits, and data analysis services. Sequencing kits are segmented into end repair, DNA fragmentation, A-Tailing and size selection, target enrichment kit and library preparation kits. On the basis of applications, the global market is classified into personalized medicine, diagnostics, agriculture and animal research and drug discovery, and development. Based on the end-users segment, the market is divided further into biotechnology companies, hospitals, research labs and academic, and government organizations.
North America is the largest market for whole exome sequencing owing to scientific awareness, advanced technology, sufficient funds available at disposal, and the interest of the government and private organizations in developing this method and making it more cost-effective. This trend is followed by Europe and Asia. Asia is anticipated to grow at considerable rate in the near future. With regular government funding and a large number of conferences on the subject of whole exome sequencing technology and methods are few of the major factors boosting the growth of the market in this region.
Some of the major players dominating the global whole exome sequencing market are BGI, Ambry Genetics, Eurofins Genomics, Inc., Life Technologies, Illumina, Inc., and GENEWIZ, Inc. The growth is due to their understanding of the technology and investments in R&D.
Whole Exome Sequencing Market: Regional Segment Analysis
- North America
- Asia Pacific
- Latin America
- Middle East and Africa